ProShare Advisors’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,041
| Closed | -$31K | – | 2013 |
|
|
2022
Q1 | $31K | Sell |
1,041
-266
| -20% | -$7.92K | ﹤0.01% | 2149 |
|
|
2021
Q4 | $56K | Buy |
+1,307
| New | +$56K | ﹤0.01% | 2274 |
|
|
2021
Q3 | – | Sell |
-919
| Closed | -$106K | – | 2178 |
|
|
2021
Q2 | $106K | Sell |
919
-33
| -3% | -$3.81K | ﹤0.01% | 2283 |
|
|
2021
Q1 | $99K | Buy |
952
+255
| +37% | +$26.5K | ﹤0.01% | 2169 |
|
|
2020
Q4 | $33K | Buy |
+697
| New | +$33K | ﹤0.01% | 2072 |
|